India Allows Pharmacopoeia Suffix Interchangeability for Export Compliance, Aligns with Handbook Procedure Note No.4.
The circular from the Directorate General of Foreign Trade, India, addresses the interchangeability of pharmacopoeia suffixes (USP, EP, BP, JP, IP) in export products for fulfilling export obligations. It clarifies that exporters holding Advance Authorization can submit export documents with a different pharmacopoeia suffix than initially specified, as these suffixes are interchangeable. This decision aligns with the existing General Note No.4 in the Hand Book of Procedure Vol. II, which allows the use of different suffixes in export licenses. The directive aims to facilitate smoother compliance with export obligations by accepting various pharmacopoeia standards.
Full Summary is availble for active users!
Note: It is a system-generated summary and is for quick
reference only.